ArticleLasers in medical science2025
Analysis of the clinical application and treatment effects of Ultra-Pulse Shockwave technology in facial rejuvenation.
Article in Lasers in medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Facial aging involves structural changes in the skin, subcutaneous tissues, and skeletal framework. Ultra-Pulse Shockwave (UPSW) therapy, a non-thermal, high-frequency shockwave technology, has emerged as a promising, non-invasive option for facial rejuvenation. This study evaluates the efficacy and safety of UPSW in improving skin texture, reducing subcutaneous fat, and enhancing skin tightness. A clinical study was conducted with 20 participants (ages 25-60) undergoing three UPSW treatment sessions over six weeks. Objective assessments included standardized photography, VISIA skin analysis, and Paragon XHD ultrasound imaging to document and analyze treatment effects. Subjective evaluations were performed using the Global Aesthetic Improvement Scale (GAIS) to measure aesthetic outcomes and the Visual Analog Scale (VAS) to assess pain levels experienced during and after treatment. UPSW therapy significantly improved skin texture (p = 0.010) and showed promising effects on subcutaneous fat reduction and skin tightness. Wrinkles (p = 0.069) and pores (p = 0.232) did not reach statistical significance. Adverse effects, including transient erythema and mild edema, were minor and self-limiting. The mean VAS pain score was 2.8, indicating high tolerability. Ultra-Pulse Shockwave (UPSW) therapy demonstrated both safety and efficacy as a non-invasive treatment for facial rejuvenation. The findings indicate that UPSW significantly enhances skin texture while exerting positive effects on skin tightening and subcutaneous fat reduction. Despite the limitations of a small sample size, limited treatment sessions, and a short follow-up period, this study highlights UPSW's potential as a valuable addition to aesthetic medicine. Further research involving larger cohorts, more frequent treatments, and extended follow-up durations is recommended to optimize treatment protocols and comprehensively evaluate its long-term benefits.
Indexed as
Identifiers
40055255What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.